Regulation of Androgen Action

Vitamins and Hormones

Volumn 55, Issue C, 1998, Pages

  Roy, A K ^a   Lavrovsky, Y ^a   Song, C S ^a   Chen, S ^a   Jung, M H ^a   Velu, N K ^a   Bi, B Y ^a   Chatterjee, B ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956684050     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60938-3     Document Type: Article

References (227)

1. Abdelgadir S.E., Roselli C.E., Choate J.V., and Resko J.A. Distribution of aromatase cytochrome P450 messenger ribonucleic acid in adult rhesus monkey brains. Biol. Reprod. 57 (1977) 772-777
2. Ahuja H.S., Tenniswood M., Lockshin R., and Zakeri Z.F. Expression of clusterin in cell differentiation and cell death. Biochem. Cell Biol. 72 (1994) 523-530
3. Allison J., Zhang Y.L., and Parker M.G. Tissue-specific and hormonal regulation of the gene for rat prostatic steroid-binding protein in transgenic mice. Mol. Cell. Biol. 9 (1989) 2254-2257
4. Anderson K.M., and Liao S. Selective retention of dihydrotestosterone by prostatic nuclei. Nature (London 219 (1968) 277-279
5. Anderson S., Geissler W.M., Wu L., Davis D.L., Grumbach M.M., New M.I., Schwarz H.P., Blethen S.L., Mendonca B.B., Bloise W., Witchel S.F., Cutler G.B.J., Griffin J.E., Wilson J.D., and Russel D.W. Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J. Clin. Endocrinol. Metab. 81 (1996) 130-136
6. Archer T.K., Lefebvre P., Wolford R.G., and Hager G.L. Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science 255 (1992) 1573-1576
7. Aronica S.M., Kraus W.L., and Katzenellenbogen B.S. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8517-8521
8. Baarends W.M., Themmen A.P., Blok L.J., Mackenbach P., Brinkmann A.O., Meijer D., Faber P.W., Trapman J., and Grootegoed J.A. The rat androgen receptor gene promoter. Mol. Cell. Endocrinol. 74 (1990) 75-84
9. Banas B., Blaschke D., Fittler F., and Horz W. Analysis of the promoter of the human prostatic acid phosphatase gene. Biochim. Biophys. Acta 1217 (1994) 188-194
10. Bannister A.J., and Kouzarides T. The CBP co-activator is a histone acetyl-transferase. Nature (London 384 (1996) 641-643
11. Baulieu E., Corpechot C., Dray F., Emiliozzi R., Lebeau M., Maurais-Jarvis P., and Robel P. An adrenal secreted "Androgen": Dehydroisoandrosterone sulfate. Its metabolism and tentative generalization on the metabolism of other steroid conjugates in man. Recent Prog. Horm. Res. 21 (1965) 411-500
12. Beato M., Herrlich P., and Schutz G. Steroid hormone receptors: Many actors in search of a plot. Cell (Cambridge, Mass. 83 (1995) 851-857
13. Beekman J.M., Allan G.F., Tsai S.Y., Tsai M.J., and O'Malley B.W. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol. Endocrinol. 7 (1993) 1266-1274
14. Bentvelsen F.M., McPhaul M.J., Wilson C.M., Wilson J.D., and George F.W. Regulation of immunoreactive androgen receptor in the adrenal gland of the adult rat. Endocrinology (Baltimore 137 (1996) 2659-2663
15. Blok L.J., Hoogerbrugge J.W., Themmen A.P., Baarends W.M., Post M., and Grootegoed J.A. Transient down-regulation of androgen receptor messenger ribonucleic acid (mRNA) expression in Sertoli cells by follicle-stimulating hormone is followed by up-regulation of androgen receptor mRNA and protein. Endocrinology (Baltimore 131 (1992) 1343-1349
16. Bremner W.J., Millar M.R., Sharpe R.M., and Saunders P.T. Immunohistochemical localization of androgen receptors in the rat testis: evidence for stage-dependent expression and regulation by androgens. Endocrinology (Baltimore 135 (1994) 1227-1234
17. Brinkmann A.O., Faber P.W., van Rooij H.C.J., Kuiper G.G., Ris C., Klaassen P., van der Korput J.A., Voorhorst M.M., van Laar J.H., and Mulder E. The human androgen receptor: Domain structure, genomic organization and regulation of expression. J. Steroid Biochem. 34 (1989) 307-310
18. Brown C.J., Goss S.J., Lubahn D.B., Joseph D.R., Wilson E.M., French F.S., and Willard H.F. Androgen receptor locus on the human X chromosome: Regional localization to Xq11-12 and description of a DNA polymorphism. Am. J. Hum. Genet. 44 (1989) 264-269
19. Bruchovsky N., and Wilson J.D. The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro. J. Biol. Chem. 243 (1968) 2012-2021
20. Bruchovsky N., Snoek R., Rennie P.S., Akakura K., Goldenberg L.S., and Gleave M. Control of tumor progression by maintenance of apoptosis. Prostate, Suppl. 6 (1996) 13-21
21. Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., and Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (London 389 (1997) 753-758
22. Buttyan R., Olsson C.A., Pintar J., Chang C., Bandyk M., Ng P.Y., and Sawczuk I.S. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol. Cell. Biol. 9 (1989) 3473-3481
23. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., and Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337 (1997) 91-95
24. Cato A.C., Henderson D., and Ponta H. The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J. 6 (1987) 363-368
25. Cavailles V., Dauvois S.L., Horset F., Lopez G., Hoare S., Kushner P.J., and Parker M.G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14 (1995) 3741-3751
26. Celotti F., and Negri C.P. Anabolic steroids: A review of their effects on the muscles, of their possible mechanisms of action and of their use in athletics. J. Steroid Biochem. Mol. Biol. 43 (1992) 469-477
27. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montminy M., and Evans R.M. Role of CBP/P300 in nuclear receptor signalling. Nature (London 383 (1996) 99-103
28. Chamberlain N.L., Driver E.D., and Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect trans-activation function. Nucleic Acids Res. 22 (1994) 3181-3186
29. Chan J., Song C.S., Matusik R.J., Chatterjee B., and Roy A.K. Inhibition of androgen action by dehydroepiandrosterone sulfotransferase transfected in PC-3 prostate cancer cells. Chem.-Biol. Interact. 109 (1998) 267-278
30. Chang C.S., Kokontis J., and Liao S.T. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240 (1988) 324-326
31. Chang C.S., Kokontis J., and Liao S.T. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 7211-7215
32. Chatterjee B., Majumdar D., Ozbilen O., Murty C.V., and Roy A.K. Molecular cloning and characterization of cDNA for androgen-repressible rat liver protein, SMP-2. J. Biol. Chem. 262 (1987) 822-825
33. Chatterjee B., Song C.S., Kim J.M., and Roy A.K. Androgen and estrogen sulfotransferases of the rat liver: Physiological function, molecular cloning, and in vitro expression. Chem.-Biol. Interact. 92 (1994) 273-279
34. Chatterjee B., Song C.S., Jung M.H., Chen S., Walter C.A., Herbert D.C., Weaker F.J., Mancini M.A., and Roy A.K. Targeted overexpression of androgen receptor with a liver-specific promoter in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 728-733
35. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., and Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell (Cambridge, Mass. 90 (1997) 569-580
36. Chen J.D., and Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (London 377 (1995) 454-457
37. Chen S., Supakar P.C., Vellanoweth R.L., Song C.S., Chatterjee B., and Roy A.K. Functional role of a conformationally flexible homopurine/homopyrimidine domain of the androgen receptor gene promoter interacting with Sp1 and a pyrimidine single strand DNA-binding protein. Mol. Endocrinol. 11 (1997) 3-15
38. Chen S., Wang J., Yu G., Liu W., and Pearce D. Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity. J. Biol. Chem. 272 (1997) 14087-14092
39. Claessens F., Celis L., De V.P., Heyns W., Verhoeven G., Peeters B., and Rombauts W. Functional androgen response elements in the genes coding for prostatic binding protein. Ann. N.Y. Acad. Sci. 684 (1993) 199-201
40. Cunha G.R. Growth factors as mediators of androgen action during male urogenital development. Prostate, Suppl. 6 (1996) 22-25
41. Cunha G.R., and Lung B. The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J. Exp. Zool. 205 (1978) 181-193
42. Cunha G.R., Chung L.W., Shannon J.M., Taguchi O., and Fujii H. Hormone-induced morphogenesis and growth: Role of mesenchymal-epithelial interactions. Recent Prog. Horm. Res. 39 (1983) 559-598
43. Dai J.L., and Bernstein K.L. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. Mol. Endocrinol. 10 (1996) 1582-1594
44. Das S.K., Taylor J.A., Korach K.S., Paria B.C., Dey S.K., and Lubahn D.B. Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12786-12791
45. Dedhar S., Rennie P.S., Shago M., Hagesteijn C.Y., Yang H., Filmus J., Hawley R.G., Bruchovsky N., Cheng H., and Matusik R.J. Inhibition of nuclear hormone receptor activity by calreticulin. Nature (London 367 (1994) 480-483
46. DeKlerk D.P., and Coffey D.S. Quantitative determination of prostatic epithelial and stromal hyperplasia by a new technique: Biomorphometrics. Invest. Urol. 16 (1978) 240-245
47. Demyan W.F., Song C.S., Kim D.S., Her S., Gallwitz W., Rao T.R., Slomczynska M., Chatterjee B., and Roy A.K. Estrogen sulfotransferase of the rat liver: complementary DNA cloning and age- and sex-specific regulation of messenger RNA. Mol. Endocrinol. 6 (1992) 589-597
48. DeVos V.P., Claessens F., Winderickx J., Van D.P., Celis L., Peeters B., Rombauts W., Heyns W., and Verhoeven G. Interaction of androgen response elements with the DNA-binding domain of the rat androgen receptor expressed in Escherichia coli. J. Biol. Chem. 266 (1991) 3439-3443
49. Doesburg P., Kuil C.W., Berrevoets C.A., Steketee K., Faber P.W., Mulder E., Brinkmann A.O., and Trapman J. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 36 (1997) 1052-1064
50. Donahoe P.K., Cate R.L., MacLaughlin D.T., Epstein J., Fuller A.F., Takahashi M., Coughlin J.P., Ninfa E.G., and Taylor L.A. Mullerian inhibiting substance: Gene structure and mechanism of action of a fetal regressor. Recent Prog. Horm. Res. 43 (1987) 431-467
51. Drews U., and Drews U. Regression of mouse mammary gland anlagen in recombinants of Tfm and wild-type tissues: Testosterone acts via the mesenchyme. Cell (Cambridge, Mass. 10 (1977) 401-404
52. Escriva H., Safi R., Hanni C., Langlois M.C., Saumitou-Laprade P., Stehelin D., Capron A., Pierce R., and Laudet V. Ligand binding was acquired during evolution of nuclear receptors. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6803-6808
53. Evans G.S., and Chandler J.A. Cell proliferation studies in the rat prostate: II. The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation. Prostate 11 (1987) 339-351
54. Evans R.M. The steroid and thyroid hormone receptor super-family. Science 240 (1988) 889-895
55. Faber P.W., King A., van Rooij H.C.J., Brinkmann A.O., de Both B.N., and Trapman J. The mouse androgen receptor. Functional analysis of the protein and characterization of the gene. Biochem. J. 278 (1991) 269-278
56. Faber P.W., van Rooij H.C.J., van der Korput H.A., Baarends W.M., Brinkmann A.O., Grootegoed J.A., and Trapman J. Characterization of the human androgen receptor transcription unit. J. Biol. Chem. 266 (1991) 10743-10749
57. Faber P.W., van Rooij H.C.J., Schipper H.J., Brinkmann A.O., and Trapman J. Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1. J. Biol. Chem. 268 (1993) 9296-9301
58. Fasciana C., van der Made A.C., Faber P.W., and Trapman J. Androgen regulation of the rat keratinocyte growth factor (KGF/FGF7) promoter. Biochem. Biophys. Res. Commun. 220 (1996) 858-863
59. Fawell S.E., Lees J.A., White R., and Parker M.G. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell (Cambridge, Mass. 60 (1990) 953-962
60. Finch P.W., Lengel C., and Chedid M. Cloning and characterization of the promoter region of the human keratinocyte growth factor gene. J. Biol. Chem. 270 (1995) 11230-11237
61. Freedman L.P. Anatomy of the steroid receptor zinc finger region. Endocr. Rev. 13 (1992) 129-145
62. Fuhrmann U., Bengtson C., Repenthin G., and Schillinger E. Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: Inhibition of cat expression by anti-androgens. J. Steroid Biochem. Mol. Biol. 42 (1992) 787-793
63. Furr B.J. Casodex: Preclinical studies and controversies. Ann. N.Y. Acad. Sci. 761 (1995) 79-96
64. Godowski P.J., Picard D., and Yamamoto K.R. Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion proteins. Science 241 (1988) 812-816
65. Golsteyn E.J., Goren H.J., Lehoux J.G., and Lefebvre Y.A. Phosphorylation and nuclear processing of the androgen receptor. Biochem. Biophys. Res. Commun. 171 (1990) 336-341
66. Gonzalez G.A., and Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell (Cambridge, Mass. 59 (1989) 675-680
67. Gottlieb B., Trifiro M., Lumbroso R., and Pinsky L. The androgen receptor gene mutations database. Nucleic Acids Res. 25 (1997) 158-162
68. Gowland P.L., and Buetti E. Mutations in the hormone regulatory element of mouse mammary tumor virus differentially affect the response to progestins, androgens, and glucocorticoids. Mol. Cell. Biol. 9 (1989) 3999-4008
69. Greenberg N.M., DeMayo F., Finegold M.J., Medina D., Tilley W.D., Aspinall J.O., Cunha G.R., Donjacour A.A., Matusik R.J., and Rosen J.M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 3439-3443
70. Grino P.B., Griffin J.E., and Wilson J.D. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology (Baltimore 126 (1990) 1165-1172
71. Grossmann M.E., and Tindall D.J. The androgen receptor is transcriptionally suppressed by proteins that bind single-stranded DNA. J. Biol. Chem. 270 (1995) 10968-10975
72. Grossmann M.E., Lindzey J., Blok L., Perry J.E., Kumar M.V., and Tindall D.J. The mouse androgen receptor gene contains a second functional promoter which is regulated by dihydrotestosterone. Biochemistry 33 (1994) 14594-14600
73. Guillemette C., Hum D.W., and Belanger A. Regulation of steroid glucurono-syltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line. Endocrinology (Baltimore 137 (1996) 2872-2879
74. Guiochon-Mantel A., Loosfelt H., Lescop P., Sar S., Atger M., Perrot-Applanat M., and Milgrom E. Mechanisms of nuclear localization of the progesterone receptor: Evidence for interaction between monomers. Cell (Cambridge, Mass. 57 (1989) 1147-1154
75. Guo L., Degenstein L., and Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 10 (1996) 165-175
76. Gurpide E. Enzymatic modulation of hormonal action at the target tissue. J. Toxicol. Environ. Health 4 (1978) 249-268
77. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C., and Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264 (1994) 1455-1458
78. Ham J., Thomson A., Needham M., Webb P., and Parker M. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Res. 16 (1988) 5263-5276
79. Harris S.E., Rong Z., Harris M.A., and Lubahn D.B. Androgen receptor in human prostate carcinoma LNCaP/ADEP cells contains a mutation which alters the specificity of the steroid-dependent transcriptional activation region. Program 72nd Annu. Meet. Endocr. Soc. Am. (1990) Abstr. No. 275
80. Heckert L.L., Wilson E.M., and Nilson J.H. Transcriptional repression of the alpha-subunit gene by androgen receptor occurs independently of DNA binding but requires the DNA-binding and ligand-binding domains of the receptor. Mol. Endocrinol. 11 (1997) 1497-1506
81. Hirst J.J., West N.B., Brenner R.M., and Novy M.J. Steroid hormone receptors in the adrenal glands of fetal and adult rhesus monkeys. J. Clin. Endocrinol. Metab. 75 (1992) 308-314
82. Ho K.C., Marschke K.B., Tan J., Power S.G., Wilson E.M., and French F.S. A complex response element in intron 1 of the androgen-regulated 20-kDa protein gene displays cell type-dependent androgen receptor specificity. J. Biol. Chem. 268 (1993) 27226-27235
83. Hobkirk R. Steroid sulfation. Current concepts. Trends Endocrinol. Metab. 4 (1993) 69-74
84. Hopper B.R., and Yen S.S. Circulating concentrations of dehydroepiandrosterone and dehydroepiandrosterone sulfate during puberty. J. Clin. Endocrinol. Metab. 40 (1975) 458-461
85. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Söderström M., and Glass C.K. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor [see comments]. Nature (London 377 (1995) 397-404
86. Horwitz K.B., Jackson T.A., Blain D.L., Richer J.K., Takimoto G.S., and Tung L. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10 (1996) 1167-1177
87. Ikonen T., Palvimo J.J., and Janne O.A. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J. Biol. Chem. 272 (1997) 29821-29828
88. Imperato-McGinley J. Benign prostatic hyperplasia: Dihydrotestosterone and 5 alpha-reductase inhibition therapy. Prog. Clin. Biol. Res. 386 (1994) 197-203
89. Imperato-McGinley J., Shackleton C., Orlic S., and Stoner E. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: Comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. J. Clin. Endocrinol. Metab. 70 (1990) 777-782
90. Isaacs J.T. Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle. J. Steroid Biochem. 18 (1983) 749-757
91. Isaacs J.T. Role of androgens in prostatic cancer. Vitam. Horm. (N.Y. 49 (1994) 433-502
92. Isaacs J.T., Furuya Y., and Berges R. The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue. Semin. Cancer Biol. 5 (1994) 391-400
93. Jacobi G.H., Moore R.J., and Wilson J.D. Studies on the mechanism of 3 alpha-androstanediol-induced growth of the dog prostate. Endocrinology (Baltimore 102 (1978) 1748-1758
94. Janknegt R.A., Abbou C.C., Bartoletti R., Bernstein-Hahn L., Bracken B., Brisset J.M., Calais DaSilva F., Chisolm G., Crawford E.D., Debruyne F.M.J., Dijkman G.D., Frick J., Goedhals L., Knonagel H., and Venner P.M. Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. J. Urol. 149 (1993) 77-83
95. Jenster G., van der Korput H.A., van Vroonhoven C., van der Kwast T.H., Trapman J., and Brinkmann A.O. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol. Endocrinol. 5 (1991) 1396-1404
96. Jenster G., van der Korput J.A., Trapman J., and Brinkmann A.O. Functional domains of the human androgen receptor. J. Steroid Biochem. Mol. Biol. 41 (1992) 671-675
97. Jenster G., Trapman J., and Brinkmann A.O. Nuclear import of the human androgen receptor. Biochem. J. 293 (1993) 761-768
98. Jenster G., de Ruiter P.E., van der Korput H.A., Kuiper G.G., Trapman J., and Brinkmann A.O. Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry 33 (1994) 14064-14072
99. Jenster G., Spencer T.E., Burcin M.M., Tsai S.Y., Tsai M.J., and O'Malley B.W. Steroid receptor induction of gene transcription: A two-step model. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 7879-7884
100. Johnson M., and Everitt B. Essential Reproduction (1988), Blackwell Scientific, Oxford
101. Josso N., Boussin L., Knebelmann B., Nihoul-Fekete C., and Picard J.Y. Anti-mullerian hormone and intersex states. Trends Endocrinol. Metab. 2 (1991) 227-233
102. Jost A. Hormonal factors in the sex differentiation of the mammalian foetus. Philos. Trans. R. Soc. London, Ser. B 259 (1970) 119-130
103. Kallio P.J., Palvimo J.J., Mehto M., and Janne O.A. Analysis of androgen receptor-DNA interactions with receptor proteins produced in insect cells. J. Biol. Chem. 269 (1994) 11514-11522
104. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., and Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (Cambridge, Mass. 85 (1996) 403-414
105. Kemppainen J.A., Lane M.V., Sar M., and Wilson E.M. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J. Biol. Chem. 267 (1992) 968-974
106. Kitay J.I., Coyne M.D., Nelson R., and Newsom W. Relation of the testis to adrenal enzyme activity and adrenal corticosterone production in the rat. Endocrinology (Baltimore 78 (1966) 1061-1075
107. Koopman P., Gubbay J., Vivian N., Goodfellow P., and Lovell-Badge R. Male development of chromosomally female mice transgenic for Sry. Nature (London 351 (1991) 117-121
108. Kratochwil K., and Schwartz P. Tissue interaction in androgen response of embryonic mammary rudiment of mouse: Identification of target tissue for testosterone. Proc. Natl. Acad. Sci. U.S.A. 73 (1976) 4041-4044
109. Krongrad A., Wilson C.M., Wilson J.D., Allman D.R., and McPhaul M.J. Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol. Cell. Endocrinol. 76 (1991) 79-88
110. Kuil C.W., and Mulder E. Effects of androgens and antiandrogens on the conformation of the androgen receptor. Ann. N.Y. Acad. Sci. 761 (1995) 351-354
111. Kuiper G.G., Faber P.W., van Rooij H.C.J., van der Korput J.A., Ris-Stalpers C., Klaassen P., Trapman J., and Brinkmann A.O. Structural organization of the human androgen receptor gene. J. Mol. Endocrinol. 2 (1989) R1-R4
112. Kuiper G.G., de Ruiter P.E., Trapman J., Boersma W.J., Grootegoed J.A., and Brinkmann A.O. Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor. Biochem. J. 291 (1993) 95-101
113. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5925-5930
114. Kumar M.V., Jones E.A., Grossmann M.E., Blexrud M.D., and Tindall D.J. Identification and characterization of a suppressor element in the 5'-flanking region of the mouse androgen receptor gene. Nucleic Acids Res. 22 (1994) 3693-3698
115. Kyprianou N., and Isaacs J.T. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology (Baltimore 122 (1988) 552-562
116. Kyprianou N., Martikainen P., Davis L., English H.F., and Isaacs J.T. Programmed cell death as a new target for prostatic cancer therapy. In: Isaacs J.T. (Ed). In "Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment" (1991), Cold Spring Harbor Lab. Press, Cold Spring Harbor, NY 265-278
117. Labrie C., Belanger A., and Labrie F. Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology (Baltimore 123 (1988) 1412-1417
118. Labrie F. Intracrinology. Mol. Cell. Endocrinol. 78 (1991) C113-C118
119. Lamas M., and Sassone-Corsi P. The dynamics of the transcriptional response to cyclic adenosine 3',5'-monophosphate: Recurrent inducibility and refractory phase. Mol. Endocrinol. 11 (1997) 1415-1424
120. Liang T., and Liao S. Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids. Biochem. J. 285 (1992) 557-562
121. Liang T., Heiss C.E., Cheung A.H., Reynolds G.F., and Rasmusson G.H. 4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor. J. Biol. Chem. 259 (1984) 734-739
122. Liao S., Liang T., Fang S., Castaneda E., and Shao T.C. Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens. J. Biol. Chem. 248 (1973) 6154-6162
123. Liao S.S., Kokontis J., Sai T., and Hiipakka R.A. Androgen receptors: Structures, mutations, antibodies and cellular dynamics. J. Steroid Biochem. 34 (1989) 41-51
124. Lindzey J., Grossmann M., Kumar M.V., and Tindall D.J. Regulation of the 5'-flanking region of the mouse androgen receptor gene by cAMP and androgen. Mol. Endocrinol. 7 (1993) 1530-1540
125. Lindzey J., Kumar M.V., Grossman M., Young C., and Tindall D.J. Molecular mechanisms of androgen action. Vitam. Horm. (N.Y. 49 (1994) 383-432
126. Lu S., Tsai S.Y., and Tsai M.J. Regulation of androgen-dependent prostatic cancer cell growth: Androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res. 57 (1997) 4511-4516
127. Lubahn D.B., Joseph D.R., Sar M., Tan J., Higgs H.N., Larson R.E., French F.S., and Wilson E.M. The human androgen receptor: Complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol. Endocrinol. 2 (1988) 1265-1275
128. Lubahn D.B., Joseph D.R., Sullivan P.M., Willard H.F., French F.S., and Wilson E.M. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240 (1988) 327-330
129. Lubahn D.B., Brown T.R., Simental J.A., Higgs H.N., Migeon C.J., Wilson E.M., and French F.S. Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 9534-9538
130. Luke M.C., and Coffey D.S. Human androgen receptor binding to the androgen response element of prostate specific antigen. J. Androl. 15 (1994) 41-51
131. Mancini M.A., Chatterjee B., and Roy A.K. Age-dependent reversal of the lobular distribution of androgen-inducible alpha 2u globulin and androgen-repressible SMP-2 in rat liver. J. Histochem. Cytochem. 39 (1991) 401-405
132. Mancini M.A., Song C.S., Rao T.R., Chatterjee B., and Roy A.K. Spatio-temporal expression of estrogen sulfotransferase within the hepatic lobule of male rats: Implication of in situ estrogen inactivation in androgen action. Endocrinology (Baltimore 131 (1992) 1541-1546
133. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., and Chambon P. The nuclear receptor superfamily: the second decade. Cell (Cambridge, Mass. 83 (1995) 835-839
134. Maroulakou I.G., Anver M., Garrett L., and Green J.E. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11236-11240
135. McEwan I.J., and Gustafsson J. Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8485-8490
136. McNeal J.E. The prostate gland: Morphology and pathobiology. Monog. Urol. 4 (1983) 3-33
137. Meyer T.E., and Habener J.F. Cyclic adenosine 3',5'-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr. Rev. 14 (1993) 269-290
138. Mhatre A.N., Trifiro M.A., Kaufman M., Kazemi-Esfarjani P., Figlewicz D., Rouleau G., and Pinsky L. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat. Genet. 5 (1993) 184-188
139. Michalak M., Milner R.E., Burns K., and Opas M. Calreticulin. Biochem. J. 285 (1992) 681-692
140. Mizokami A., and Chang C. Induction of translation by the 5'-untranslated region of human androgen receptor mRNA. J. Biol. Chem. 269 (1994) 25655-25659
141. Mizokami A., Yeh S.Y., and Chang C. Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Mol. Endocrinol. 8 (1994) 77-88
142. Mooradian A.D., Morley J.E., and Korenman S.G. Biological actions of androgens. Endocr. Rev. 8 (1987) 1-28
143. Mora G.R., and Mahesh V.B. Autoregulation of androgen receptor in rat ventral prostate: Involvement of c-fos as a negative regulator. Mol. Cell. Endocrinol. 124 (1996) 111-120
144. Mortola J.F., and Yen S.S. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J. Clin. Endocrinol. Metab. 71 (1990) 696-704
145. Mosselman S., Polman J., and Dijkema R. ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett. 392 (1996) 49-53
146. Murray M.B., and Towle H.C. Identification of nuclear factors that enhance binding of the thyroid hormone receptor to a thyroid hormone response element. Mol. Endocrinol. 3 (1989) 1434-1442
147. Murtha P., Tindall D.J., and Young C.Y. Androgen induction of a human prostate-specific kallikrein, hKLK2: Characterization of an androgen response element in the 5' promoter region of the gene. Biochemistry 32 (1993) 6459-6464
148. Nakhla A.M., Romas N.A., and Rosner W. Estradiol activates the prostate androgen receptor and prostate-specific antigen secretion through the intermediacy of sex hormone-binding globulin. J. Biol. Chem. 272 (1997) 6838-6841
149. Nash A.R., Glenn W.K., Moore S.S., Kerr J., Thompson A.R., and Thompson E.O. Oestrogen sulfotransferase: Molecular cloning and sequencing of cDNA for the bovine placental enzyme. Aust. J. Biol. Sci. 41 (1988) 507-516
150. Nemoto T., Ohara-Nemoto Y., Shimazaki S., and Ota M. Dimerization characteristics of the DNA- and steroid-binding domains of the androgen receptor. J. Steroid Biochem. Mol. Biol. 50 (1994) 225-233
151. Neri R., Peets E., and Watnick A. Anti-androgenicity of flutamide and its metabolite Sch 16423. Biochem. Soc. Trans. 7 (1979) 565-569
152. Neumann F., and Jacobi G.H. Antiandrogens in tumor therapy. Clin. Oncol. 1 (1982) 41-65
153. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell (Cambridge, Mass. 87 (1996) 953-969
154. Ogura K., Kajita J., Narihata H., Watabe T., Ozawa S., Nagata K., Yamazoe Y., and Kato R. Cloning and sequence analysis of a rat liver cDNA encoding hydroxysteroid sulfotransferase. Biochem. Biophys. Res. Commun. 165 (1989) 168-174
155. Onate S.A., Tsai S.Y., Tsai M.J., and O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354-1357
156. Orentreich N., Brind J.L., Vogelman J.H., Andres R., and Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J. Clin. Endocrinol. Metab. 75 (1992) 1002-1004
157. Palvimo J.J., Reinikainen P., Ikonen T., Kallio P.J., Moilanen A., and Janne O.A. Mutual transcriptional interference between RelA and androgen receptor. J. Biol. Chem. 271 (1996) 24151-24156
158. Parker L.N., and Odell W.D. Control of adrenal androgen secretion. Endocr. Rev. 1 (1980) 392-410
159. Penning T.M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr. Rev. 18 (1997) 281-305
160. Picard D., and Yamamoto K.R. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 6 (1987) 3333-3340
161. Quarmby V.E., Kemppainen J.A., Sar M., Lubahn D.B., French F.S., and Wilson E.M. Expression of recombinant androgen receptor in cultured mammalian cells. Mol. Endocrinol. 4 (1990) 1399-1407
162. Quigley C.A., De B.A., Marschke K.B., el-Awady M.K., Wilson E.M., and French F.S. Androgen receptor defects: Historical, clinical, and molecular perspectives. Endocr. Rev. 16 (1995) 271-321
163. Ray A., and Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 752-756
164. Rennie P.S., Bruchovsky N., Leco K.J., Sheppard P.C., McQueen S.A., Cheng H., Snoek R., Hamel A., Bock M.E., and MacDonald B.S. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol. Endocrinol. 7 (1993) 23-36
165. Riegman P.H., Vlietstra R.J., van der Korput J.A., Brinkmann A.O., and Trapman J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol. 5 (1991) 1921-1930
166. Ringold G.M., Yamamoto K.R., Bishop J.M., and Varmus H.E. Glucocorticoid-stimulated accumulation of mouse mammary tumor virus RNA: Increased rate of systhesis of viral RNA. Proc. Natl. Acad. Sci. U.S.A. 74 (1988) 2879-2883
167. Rittmaster R.S., Leopold C.A., and Thompson D.L. Androgen glucuronyl transferase activity in rat liver, evidence for the importance of hepatic tissue in 5 alpha-reduced androgen metabolism. J. Steroid Biochem. 33 (1989) 1207-1212
168. Robins D.M., Scheller A., and Adler A.J. Specific steroid response from a non-specific DNA element. J. Steroid Biochem. Mol. Biol. 49 (1994) 251-255
169. Roche P.J., Hoare S.A., and Parker M.G. A consensus DNA-binding site for the androgen receptor. Mol. Endocrinol. 6 (1992) 2229-2235
170. Roy A.K. Regulation of steroid hormone action in target cells by specific hormone-inactivating enzymes. Proc. Soc. Exp. Biol. Med. 199 (1992) 265-272
171. Roy A.K., and Chatterjee B. Androgen action. Crit. Rev. Eukaryotic Gene Expression 5 (1995) 157-176
172. Roy A.K., Vellanoweth R.L., Jung M.H., and Chatterjee B. Cellular and molecular effects of androgenic-anabolic steroids. In: Thomas J.A., and Colby H.D. (Eds). In "Endocrine. Toxicology". 2nd ed. (1997), Taylor & Francis, Washington, DC 213-225
173. Roy R., and Belanger A. ZR-75-1 breast cancer cells generate nonconjugated steroids from low density lipoprotein-incorporated lipoidal dehydroepiandrosterone. Endocrinology (Baltimore 133 (1993) 683-689
174. Ruizeveld de Winter J.A., Trapman J., Vermey M., Mulder E., Zegers N.D., and van der Kwast T.H. Androgen receptor expression in human tissues: an immunohistochemical study. J. Histochem. Cytochem. 39 (1991) 927-936
175. Rundlett S.E., Wu X.P., and Miesfeld R.L. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation. Mol. Endocrinol. 4 (1990) 708-714
176. Russell D.W., and Wilson J.D. Steroid 5 alpha-reductase: Two gene/two enzymes. Annu. Rev. Biochem. 63 (1994) 25-61
177. Sanborn B.M., Caston L.A., Chang C., Liao S., Speller R., Porter L.D., and Ku C.Y. Regulation of androgen receptor mRNA in rat Sertoli and peritubular cells. Biol. Reprod. 45 (1991) 634-641
178. Sato N., Sadar M.D., Bruchovsky N., Saatcioglu F., Rennie P.S., Sato S., Lange P.H., and Gleave M.E. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J. Biol. Chem. 272 (1997) 17485-17494
179. Schneider J.J. Conversion of desoxycorticosterone to four allopregnane metabolites by rat liver in vitro. J. Biol. Chem. 199 (1952) 235-244
180. Schneikert J., Peterziel H., Defossez P.A., Klocker H., Launoit Y., and Cato A.C. Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J. Biol. Chem. 271 (1996) 23907-23913
181. Shan L.X., Bardin C.W., and Hardy M.P. Immunohistochemical analysis of androgen effects on androgen receptor expression in developing Leydig and Sertoli cells. Endocrinology (Baltimore 138 (1997) 1259-1266
182. Sheridan P.J. Can a single androgen receptor fill the bill?. Mol. Cell. Endocrinol. 76 (1991) C39-C45
183. Simard J., Rheaume E., Mebarki F., Sanchez R., New M.I., Morel Y., and Labrie F. Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency. J. Steroid Biochem. Mol. Biol. 53 (1995) 127-138
184. Simental J.A., Sar M., Lane M.V., French F.S., and Wilson E.M. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem. 266 (1991) 510-518
185. Simental J.A., Sar M., and Wilson E.M. Domain functions of the androgen receptor. J. Steroid Biochem. Mol. Biol. 43 (1992) 37-41
186. Sleddens H.F., Oostra B.A., Brinkmann A.O., and Trapman J. Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene. Hum. Mol. Genet. 2 (1992) 493
187. Smith C.L., and Hager G.L. Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J. Biol. Chem. 272 (1997) 27493-27496
188. Song C.S., Her S., Slomczynska M., Choi S.J., Jung M.H., Roy A.K., and Chatterjee B. A distal activation domain is critical in the regulation of the rat androgen receptor gene promoter. Biochem. J. 294 (1993) 779-784
189. Song C.S., Jung M.H., Kim S.C., Hassan T., Roy A.K., and Chatterjee B. Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter. J. Biol. Chem. 273 (1998) 21856-21866
190. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J., Mizzen C.A., McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.J., and O'Malley B.W. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature (London 389 (1997) 194-198
191. Strott C.A. Steroid sulfotransferases. Endocr. Rev. 17 (1996) 670-697
192. Supakar P.C., and Roy A.K. Role of transcription factors in the age-dependent regulation of the androgen receptor gene in rat liver. Biol. Signals 5 (1996) 170-179
193. Supakar P.C., Song C.S., Jung M.H., Slomczynska M.A., Kim J.M., Vellanoweth R.L., Chatterjee B., and Rov A.K. A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene. J. Biol. Chem. 268 (1993) 26400-26408
194. Supakar P.C., Jung M.H., Song C.S., Chatterjee B., and Roy A.K. Nuclear factor kappa B functions as a negative regulator for the rat androgen receptor gene and NF-kappa B activity increases during the age-dependent desensitization of the liver. J. Biol. Chem. 270 (1995) 837-842
195. Takeshita A., Yen P.M., Misiti S., Cardona G.R., Liu Y., and Chin W.W. Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology (Baltimore 137 (1996) 3594-3597
196. Tan J.A., Marschke K.B., Ho K.C., Perry S.T., Wilson E.M., and French F.S. Response elements of the androgen-regulated C3 gene. J. Biol. Chem. 267 (1992) 4456-4466
197. Taurog J.D., Moore R.J., and Wilson J.D. Partial characterization of the cytosol 3alpha-hydroxysteroid:NAD(P)+ oxidoreductase of rat ventral prostate. Biochemistry 14 (1975) 810-817
198. Thompson E.A., and Siiteri P.K. Studies on the aromatization of C-19 androgens. Ann. N.Y. Acad. Sci. 212 (1973) 378-391
199. Tilley W.D., Marcelli M., Wilson J.D., and McPhaul M.J. Characterization and expression of a cDNA encoding the human androgen receptor. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 327-331
200. Tilley W.D., Marcelli M., and McPhaul M.J. Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines. J. Biol. Chem. 265 (1990) 13776-13781
201. Toscano V., Caiola S., Maroder M., Adamo M.V., Argiolas L., Familiari A., and Familiari G. Effects of dihydrotestosterone treatment on adrenal gland function and morphology in adult female guinea-pigs. J. Steroid Biochem. 36 (1990) 89-97
202. Toth M., and Zakar T. Relative binding affinities of testosterone, 19-nortestosterone and their 5 alpha-reduced derivatives to the androgen receptor and to other androgen-binding proteins: A suggested role of 5 alpha-reductive steroid metabolism in the dissociation of "myotropic" and "androgenic" activities of 19-nortestosterone. J. Steroid Biochem. 17 (1982) 653-660
203. Trapman J., Klaassen P., Kuiper G.G., van der Korput J.A., Faber P.W., van Rooij H.C.J., van Geurts K., Voorhorst M.M., Mulder E., and Brinkmann A.O. Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem. Biophys. Res. Commun. 153 (1988) 241-248
204. Truss M., Bartsch J., Schelbert A., Hache R.J., and Beato M. Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J. 14 (1995) 1737-1751
205. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63 (1994) 451-486
206. Tsai S.Y., Carlstedt-Duke J., Weigel N.L., Dahlman K., Gustafsson J.A., Tsai M.J., and O'Malley B.W. Molecular interactions of steroid hormone receptor with its enhancer element: Evidence for receptor dimer formation. Cell (Cambridge, Mass. 55 (1988) 361-369
207. Tut T.G., Ghadessy F.J., Trifiro M.A., Pinsky L., and Yong E.L. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J. Clin. Endocrinol. Metab. 82 (1997) 3777-3782
208. Umesono K., and Evans R.M. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell (Cambridge, Mass. 57 (1989) 1139-1146
209. Veldscholte J., Ris-Stalpers C., Kuiper G.G., Jenster G., Berrevoets C., Claassen E., van Rooij H.C.J., Trapman J., Brinkmann A.O., and Mulder E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun. 173 (1990) 534-540
210. Vornberger W., Prins G., Musto N.A., and Suarez-Quian C.A. Androgen receptor distribution in rat testis: New implications for androgen regulation of spermatogenesis. Endocrinology (Baltimore 134 (1994) 2307-2316
211. Wang Z., Tufts R., Haleem R., and Cai X. Genes regulated by androgen in the rat ventral prostate. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12999-13004
212. Wilson C.M., and McPhaul M.J. A and B forms of the androgen receptor are present in human genital skin fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1234-1238
213. Wilson J.D. Androgen abuse by athletes. Endocr. Rev. 9 (1988) 181-199
214. Wilson J.D. Role of dihydrotestosterone in androgen action. Prostate, Suppl. 6 (1996) 88-92
215. Wilson J.D., Griffin J.E., and Russell D.W. Steroid 5 alpha-reductase 2 deficiency. Endocr. Rev. 14 (1993) 577-593
216. Winneker R.C., Wagner M.M., and Batzold F.H. Studies on the mechanism of action of win a steroidal androgen receptor antagonist. J. Steroid Biochem. 33 (1989) 1133-1138
217. Wiren K.M., Zhang X., Chang C., Keenan E., and Orwoll E.S. Transcriptional up-regulation of the human androgen receptor by androgen in bone cells. Endocrinology (Baltimore 138 (1997) 2291-2300
218. Wolf D.A., Herzinger T., Hermeking H., Blaschke D., and Horz W. Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol. Endocrinol. 7 (1993) 924-936
219. Wong C., Kelce W.R., Sar M., and Wilson E.M. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J. Biol. Chem. 270 (1995) 19998-20003
220. Wong C.I., Zhou Z.X., Sar M., and Wilson E.M. Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains. J. Biol. Chem. 268 (1993) 19004-19012
221. Wood T.C., Her C., Aksoy I., Otterness D.M., and Weinshilboum R.M. Human dehydroepiandrosterone sulfotransferase pharmacogenetics: quantitative Western analysis and gene sequence polymorphisms. J. Steroid Biochem. Mol. Biol. 59 (1996) 467-478
222. Yan G., Fukabori Y., Nikolaropoulos S., Wang F., and McKeehan W.L. Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. Mol. Endocrinol. 6 (1992) 2123-2128
223. Yeh S., and Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5517-5521
224. Zhou Z., Corden J.L., and Brown T.R. Identification and characterization of a novel androgen response element composed of a direct repeat. J. Biol. Chem. 272 (1997) 8227-8235
225. Zhou Z.-X., Sar M., Simental J.A., Lane M.V., and Wilson E.M. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J. Biol. Chem. 269 (1994) 13115-13123
226. Zhou Z.-X., Wong C.I., Sar M., and Wilson E.M. The androgen receptor: An overview. Recent Prog. Horm. Res. 49 (1994) 249-274
227. Zhou Z.-X., Lane M.V., Kemppainen J.A., French F.S., and Wilson E.M. Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9 (1995) 208-218